Stock Yearly Return 2019
Start date: 12/31/2018
End date: 12/31/2019
Start price/share: $2.07
End price/share: $1.90
Dividends collected/share: $0.00
Total return: -8.21%
Average Annual Total Return: -8.21%
Starting investment: $10,000.00
Ending investment: $9,179.00
Years: 1.00


RSLS average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare RSLS average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into RSLS


Also see:
RSLS stock yearly return 2020
RSLS YTD return
RSLS average annual return 10 years
ReShape Lifesciences is a medical device company focused on developing and commercializing medical devices to treat people with obesity. Co.'s product offering is the Obalon Balloon System. The Obalon Balloon System consists of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement without x-ray; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with its proprietary mixture of gas. The RSLS stock yearly return is shown above.

The yearly return on the RSLS stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2019 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the RSLS annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for RSLS:
RSLS SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ReShape Lifesciences (RSLS) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

RTIX Average Annual Return
RTRX Average Annual Return
RTTR Average Annual Return
RVNC Average Annual Return
RXDX Average Annual Return
RXII Average Annual Return
RYTM Average Annual Return
SAGE Average Annual Return
SBPH Average Annual Return
SCPH Average Annual Return
More Healthcare companies »

 

RSLS Stock Yearly Return 2019 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.